BE865370A - Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate - Google Patents

Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate

Info

Publication number
BE865370A
BE865370A BE186315A BE186315A BE865370A BE 865370 A BE865370 A BE 865370A BE 186315 A BE186315 A BE 186315A BE 186315 A BE186315 A BE 186315A BE 865370 A BE865370 A BE 865370A
Authority
BE
Belgium
Prior art keywords
type compound
phosphonate
salicylate
compositions containing
inflammatory compositions
Prior art date
Application number
BE186315A
Other languages
English (en)
French (fr)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BE865370A publication Critical patent/BE865370A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
BE186315A 1977-03-28 1978-03-28 Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate BE865370A (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US78214377A 1977-03-28 1977-03-28
US78214477A 1977-03-28 1977-03-28
US80170577A 1977-05-31 1977-05-31
US80170477A 1977-05-31 1977-05-31
US80189677A 1977-05-31 1977-05-31
US80189577A 1977-05-31 1977-05-31
US80170777A 1977-05-31 1977-05-31
SE7806449A SE441493B (sv) 1977-03-28 1978-06-01 Antiinflammatorisk komposition innefattande en salicylsyrabaserad, antiinflammatorisk forening och ett organofosfonat
CH601678A CH645542A5 (de) 1977-03-28 1978-06-01 Entzuendungshemmende arzneimittelpraeparate.
SE8001363A SE441494B (sv) 1977-03-28 1980-02-21 Antiinflammatorisk komposition innefattande en indolbaserad, antiinflammatorisk forening och ett organofosfonat

Publications (1)

Publication Number Publication Date
BE865370A true BE865370A (fr) 1978-09-28

Family

ID=27579075

Family Applications (1)

Application Number Title Priority Date Filing Date
BE186315A BE865370A (fr) 1977-03-28 1978-03-28 Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate

Country Status (11)

Country Link
US (1) US4269828A (xx)
JP (1) JPS542340A (xx)
AU (1) AU524180B2 (xx)
BE (1) BE865370A (xx)
CA (1) CA1109794A (xx)
CH (1) CH645542A5 (xx)
DE (1) DE2813165C2 (xx)
FR (1) FR2385398A1 (xx)
GB (1) GB1588284A (xx)
NL (2) NL175882B (xx)
SE (2) SE441493B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
CA1229554A (en) * 1983-04-18 1987-11-24 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPH0639449B2 (ja) * 1989-04-10 1994-05-25 エーザイ株式会社 ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
SK160994A3 (en) * 1992-06-30 1996-01-10 Procter & Gamble Pharma Compositions for the treatment of arthritis containing phosphonates and nsaid
SE9303740L (sv) * 1993-11-12 1995-05-13 Leiras Oy Farmaceutisk komposition
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1997013519A1 (en) * 1995-10-09 1997-04-17 Russinsky Limited Esters of cyclooxygenase inhibitors and terpene derivatives as pharmaceutical products
DE19615577A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
DE10049735A1 (de) * 2000-09-28 2002-04-18 Jenapharm Gmbh Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
AU2010239081C1 (en) * 2009-04-24 2014-11-06 Iceutica Pty Ltd A novel formulation of indomethacin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584125A (en) * 1968-12-23 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553315A (en) * 1968-12-24 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3678164A (en) * 1969-02-12 1972-07-18 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3641246A (en) * 1970-01-14 1972-02-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue
US3662066A (en) * 1970-03-04 1972-05-09 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4044125A (en) * 1975-07-18 1977-08-23 Eli Lilly And Company Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin

Also Published As

Publication number Publication date
DE2813165A1 (de) 1978-10-12
FR2385398B1 (xx) 1980-04-04
SE441494B (sv) 1985-10-14
CA1109794A (en) 1981-09-29
US4269828A (en) 1981-05-26
SE441493B (sv) 1985-10-14
CH645542A5 (de) 1984-10-15
AU3451178A (en) 1979-10-04
NL7803247A (nl) 1978-10-02
NL175882C (nl)
AU524180B2 (en) 1982-09-02
JPS542340A (en) 1979-01-09
GB1588284A (en) 1981-04-23
SE7806449L (sv) 1979-12-02
FR2385398A1 (fr) 1978-10-27
NL175882B (nl) 1984-08-16
DE2813165C2 (de) 1983-12-15
SE8001363L (sv) 1980-02-21

Similar Documents

Publication Publication Date Title
BE865370A (fr) Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate
BE837579A (fr) Compositions destinees a l'hygiene buccale
PT66932B (pt) Metaphenylenediamines et compositions tinctoriales les contenant
IT1088703B (it) Architettura di un microelaboratore
IT1067667B (it) Composizione farmaceutica a cessione protratta
FR2344287A1 (fr) Compositions pharmaceutiques anti-inflammatoires
IT1100826B (it) Metro a nastro avvolgibile
PH12363A (en) Oral pharmaceutical compositions of nandrolone-17 esters with a non-steroidal lipoid
FR2530143B1 (fr) Composition medicinale contenant du pirprofen
IT1114216B (it) Composizioni tensionattive comprendenti un miscuglio di due tipi di poliesteri
SE425171B (sv) Pulverformig detergentkomposition innehallande en syntetisk detergentforenig och blandade fosfat
BE862850A (fr) Compositions medicamenteuses a usage oral
BE856811A (fr) Compositions pharmaceutiques basiques renfermant un preservateur
IT7949884A0 (it) Composti retinoidi e composizioni farmaceutiche ad azione anti-carcinogenica che li contengono
FR2304807A1 (fr) Moyens d'interverrouillage de panneaux
FR2297890A1 (fr) Polyesters resistant a l'inflammation
BE839411A (fr) Compositions pharmaceutiques contenant un metal lourd
IT1061581B (it) Composti bis biguanidici e composizioni orali che li contengono
FR2350380A1 (fr) Composition photodurcissable pour constituer un revetement
IT1202352B (it) Composizione antimicrobica costituita da un composto arilico doppiamente sostituito
BE862310A (fr) Compositions analgesiques et anti-inflammatoires
BE853934A (fr) Compositions a recurer
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
BR7704803A (pt) Composicao para tornar a prova do fogo materiais de varios tipos
BE849807A (fr) Compositions detergentes contenant notamment un ether de glyceryle

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE PROCTER & GAMBLE CY

Effective date: 19860331